CLINICAL_TRIALS
trial_result
· 2009-08-07
Clinical Trial Update: Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People [Phase 2]
Summary
A phase 2 clinical trial evaluating whether thalidomide can stimulate T cells in people with HIV; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED